Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeiger Counter Regulatory News (GCL)

Share Price Information for Geiger Counter (GCL)

Share Price is delayed by 15 minutes
Get Live Data
72.80    2.20 (3.13%)
Bid:
71.00
Ask:
74.60
Spread: 3.60 (5.07%)
Market Cap: £91.33m
GCL Live PriceLast checked at - London Stock Exchange

Intraday Geiger Counter Share Chart

Monthly Factsheet- April 2025

22 May 2025 10:55

RNS Number : 7965J
Geiger Counter Ltd
22 May 2025
 

 

 

Geiger Counter Limited Plc 

 

Monthly Investor Report 22 May 2025

(All Factsheet data is at 30 April 2025)

 

The full monthly factsheet is now available on the Company's website and a summary can be found below. 

 

NCIM - Geiger Counter Ltd - Fund Page for Geiger Counter Ltd

 

 

Enquiries: 

 

For the Investment Manager 

Craig Cleland 

Manulife CQS Investment Management

0207 201 5368 

For the Company Secretary and Administrator 

R&H Fund Services (Jersey) Limited

Jane De Barros/Katie De La Cour

01534 825259/01534 825337 

 

----------------------------------------------------------------------- 

 

 

Fund Description 

 

The objective of Geiger Counter Limited is to provide investors with the potential for capital growth through investment primarily in the securities of companies involved in the exploration, development and production of energy, predominantly within the uranium industry. Up to 30% of the value of the Company's investment portfolio may be invested in other resource- related companies from outside the energy sector.

 

Portfolio Managers 

 

Keith Watson and Robert Crayfourd 

 

 

Key Advantages for the Investor 

· Access to mining assets in the uranium sector

· May benefit from embedded subscription share

· Low correlation to major asset classes

 

 

 

Key Fund Facts1 

 

 

Total Gross Assets 

£58.6m

Reference Currency 

GBP 

Ordinary Shares: 

Net Asset Value 

36.76p 

Mid-Market Price  

33.80p 

Net gearing4 

20.44% 

Discount 

(8.05%) 

 

 

Ordinary Share and NAV Performance2 

 

 

One Month 

Three Months 

One Year 

Three Years 

Five Years 

 

(%) 

(%) 

(%) 

(%) 

(%) 

NAV 

7.20 

(31.76) 

(49.18) 

(30.88)

129.18

Share Price 

0.30

(34.11) 

(37.75)

(48.40) 

111.25 

 

 

Commentary3 

 

 

After a torrid year-to-date performance from the uranium mining sector despite positive demand developments, the month began to show to some price recovery. This sell off appears to have been led by speculative flows following the release of the Chinese DeepSeek Artificial Intelligence (AI) model dampening power demand expectations, but the trend to greater AI power demand clearly remains.

 

Despite weakness in the spot uranium price and corresponding miners, we believe fundamentals for the sector remain positive. China announced towards the end of the month that it had approved the construction of 10 new reactors for a combined cost of $27bn. This represents a cost/GW of just a sixth of what was invested by EDF for the Hinkley Point reactor in the UK. China had 30 reactors under construction coming into April and this latest announcement means the country will represent the majority share of the total number of reactors being built globally. With over 150 additional reactors (with 180GW capacity) in its development pipeline, the nation's technical standardisation will likely pay dividends in optimising its overall roll out costs. China is targeting nuclear generation capacity of 65GW by the end of 2025 and 200GW by 2040. In comparison the EU has 98GW, a similar level to the US.

 

Elsewhere, Japanese nuclear regulators also approved the first reactor restart in four years, with Hokkaido Electric's Tomari 3 reactor, which had been shut since 2012, given clearance to restart. It was notable that Spain suffered a grid collapse during the month, with the effects reaching into Portugal and some southern regions of France. Although Spain's grid operator has yet to clarify the cause, several prior warnings of grid instability emerged following some localised blackouts in the prior week. In addition, given the cascade was triggered in the southern region that had a heavy 55% solar loading just before the blackout, it is difficult to escape the conclusion that the grid was unable to offset the instability using conventional baseload power sources.

The event may add pressure for Spain to reconsider its planned premature power station closures. As with a prior blackout in Texas when wind turbines froze in the winter of 2021, the event may also focus regulators globally on instability that can result from too high a variable power loading. We believe this further strengthens the case for nuclear in the power mix as the only zero carbon baseload power generator to help balance out such fluctuations. This will also likely support life extension of western reactors and the accelerated small modular reactor (SMR) development later this decade.

 

The announcement from China helped revive the spot U3O8 (uranium) price which rose 5% to end April at $67.5/lb and equities recovered well with the Company NAV rising 7% compared to a 4% sterling return registered by the Solactive Uranium Pure Play Index. Notable positive contributors were made by Nexgen and Ur-Energy.

 

 

 

 

Gross Leverage6

(%)

Commitment Leverage7

(%)

Geiger Counter Ltd 

120

120

 

 

CQS (UK) LLP

4th Floor, One Strand, London WC2N 5HR, United Kingdom

T: +44 (0) 20 7201 6900 | F: +44 (0) 20 7201 1200

 

CQS (US), LLC

152 West 57th Street, 40th Floor, New York, NY 10019, US

T: +1 212 259 2900 | F: +1 212 259 2699

 

Tavistock Communications

18 St. Swithin's Lane, London EC4N 8AD

T: +44 20 7920 3150 | geigercounter@tavistock.co.uk

 

Sources: 1R&H Fund Services (Jersey) Limited, as at the last business day of the month indicated at the top of this report. 2R&H Fund Services Limited/DataStream, as at the last business day of the month indicated at the top of this report, total return performance net of fees and expenses based on bid prices. These include historic returns and past performance is not a reliable indicator of future results. The value of investments can go down as well as up. Please read the important legal notice at the end of this document. 3Market data sourced from Bloomberg unless otherwise stated. The Fund may since have exited some or all of the positions detailed in the commentary. 4 BMO, UxC, Company data September 2023. 5 www.eia.gov. 6CQS, as at the last business day of the month indicated at the top of this report. For methodology details see Article 4(3) of Directive 2011/61/EU (AIFMD) and Articles 6, 7, 9 and 10 of Delegated Regulation 231/2013. 7CQS, as at the last business day of the month indicated at the top of this report. For methodology details see Article 4(3) of Directive 2011/61/EU (AIFMD) and Articles 6, 8, 9, 10 and 11 of Delegated Regulation 231/2013.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCPPUGAAUPAUBP
Date   Source Headline
11th Aug 20253:16 pmRNSNet Asset Value(s)
11th Aug 20259:30 amRNSShare Buyback
8th Aug 20255:16 pmRNSTotal Voting Rights - Replacement
8th Aug 20255:10 pmRNSNet Asset Value(s)
8th Aug 20254:48 pmRNSShare Buyback
8th Aug 20257:00 amRNSResults of General Meeting
7th Aug 20253:04 pmRNSNet Asset Value(s)
7th Aug 20259:58 amRNSTotal Voting Rights
7th Aug 20259:54 amRNSShare Buyback
6th Aug 20251:17 pmRNSNet Asset Value(s)
5th Aug 20253:13 pmRNSNet Asset Value(s)
4th Aug 20255:08 pmRNSNet Asset Value(s)
1st Aug 20255:21 pmRNSNet Asset Value(s)
1st Aug 202511:52 amRNSShare Buyback
31st Jul 20252:35 pmRNSNet Asset Value(s)
30th Jul 20254:36 pmRNSNet Asset Value(s)
29th Jul 20253:54 pmRNSNet Asset Value(s)
28th Jul 20253:11 pmRNSNet Asset Value(s)
28th Jul 20258:33 amRNSNet Asset Value(s)
24th Jul 20254:32 pmRNSNet Asset Value(s)
24th Jul 20251:49 pmRNSShare Buyback
23rd Jul 20255:13 pmRNSMonthly Factsheet- June 2025
23rd Jul 202512:59 pmRNSNet Asset Value(s)
23rd Jul 202510:16 amRNSShare Buyback
22nd Jul 20253:01 pmRNSNet Asset Value(s)
22nd Jul 20258:15 amRNSShare Buyback
21st Jul 20253:57 pmRNSNet Asset Value(s)
21st Jul 20257:00 amRNSNotice of GM - 7 August 2025
18th Jul 20253:05 pmRNSNet Asset Value(s)
17th Jul 202512:47 pmRNSNet Asset Value(s)
17th Jul 20259:54 amRNSShare Buyback
16th Jul 20253:54 pmRNSNet Asset Value(s)
16th Jul 202510:13 amRNSShare Buyback
15th Jul 20252:52 pmRNSNet Asset Value(s)
14th Jul 20252:48 pmRNSNet Asset Value(s)
11th Jul 20253:22 pmRNSNet Asset Value(s)
10th Jul 20253:00 pmRNSNet Asset Value(s)
10th Jul 20252:48 pmRNS-RAnnual Overview from QuotedData
9th Jul 20254:23 pmRNSNet Asset Value(s)
9th Jul 202510:20 amRNSShare Buyback
8th Jul 20251:12 pmRNSNet Asset Value(s)
8th Jul 20259:57 amRNSShare Buyback
7th Jul 20253:48 pmRNSNet Asset Value(s)
7th Jul 20259:17 amRNSShare Buyback
4th Jul 202512:47 pmRNSNet Asset Value(s)
4th Jul 20258:58 amRNSShare Buyback
3rd Jul 20253:22 pmRNSNet Asset Value(s)
2nd Jul 20253:24 pmRNSNet Asset Value(s)
2nd Jul 20259:27 amRNSShare Buyback
1st Jul 20253:59 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.